Literature DB >> 10098104

Predictive performance of a semiparametric method to estimate population pharmacokinetic parameters using NONMEM.

F Bressolle1, R Gomeni.   

Abstract

Routine clinical pharmacokinetic (PK) data collected from patients receiving inulin were analyzed to estimate population PK parameters; 560 plasma concentration determinations for inulin were obtained from 90 patients. The data were analyzed using NONMEM. The population PK parameters were estimated using a Constrained Longitudinal Splines (CLS) semiparametric approach and a first-order conditional method (FOCE). The mean posterior individual clearance values were 7.73 L/hr using both parametric and semiparametric methods. This estimation was compared with clearances estimated using standard nonlinear weighted least squares approach (reference value, 7.64 L/hr). The bias was not statistically different from zero and the precision of the estimates was 0.415 L/hr using parametric method and 0.984 L/hr using semiparametric method. To evaluate the predictive performances of the population parameters, 17 new subjects were used. First, the individual inulin clearance values were estimated from drug concentration-time curve using a nonlinear weighted least-squares method then they were estimated using the NONMEM POSTHOC method obtained using parametric and CLS methods as well as an alternative method based on a Monte Carlo simulation approach. The population parameters combined with two individual inulin plasma concentrations (0.25 and 2 hr) led to an estimation of individual clearances without bias and with a good precision. This paper not only evaluates the relative performance of the parametric and the CLS methods for sparse data but also introduces a new method for individual estimation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10098104     DOI: 10.1023/a:1023289527297

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  5 in total

1.  Observations on the renal clearance and the volume of distribution of polyfructosan-S, a new inulin-like substance.

Authors:  D P MERTZ
Journal:  Experientia       Date:  1963-05-15

Review 2.  Measurement of renal function in chronic renal disease.

Authors:  A S Levey
Journal:  Kidney Int       Date:  1990-07       Impact factor: 10.612

3.  OMNE: a new robust membership-set estimator for the parameters of nonlinear models.

Authors:  H Lahanier; E Walter; R Gomeni
Journal:  J Pharmacokinet Biopharm       Date:  1987-04

4.  Some suggestions for measuring predictive performance.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1981-08

5.  Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1981-10
  5 in total
  3 in total

1.  Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.

Authors:  D R H Huntjens; A Strougo; A Chain; A Metcalf; S Summerfield; D J M Spalding; M Danhof; O Della Pasqua
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

2.  Semiparametric distributions with estimated shape parameters.

Authors:  Klas J F Petersson; Eva Hanze; Radojka M Savic; Mats O Karlsson
Journal:  Pharm Res       Date:  2009-07-01       Impact factor: 4.200

3.  Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations.

Authors:  Bernard Georges; Jean-Marie Conil; Stéphanie Ruiz; Thierry Seguin; Pierre Cougot; Olivier Fourcade; Georges Houin; Sylvie Saivin
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.